Latest Insider Transactions at Cardinal Health Inc (CAH)
This section provides a real-time view of insider transactions for Cardinal Health Inc (CAH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CARDINAL HEALTH INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CARDINAL HEALTH INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2021
|
Stephen M Mason CEO, GMPD Segment |
BUY
Grant, award, or other acquisition
|
Direct |
21,277
+21.16%
|
-
|
|
Aug 15
2021
|
Michele Holcomb EVP - Strategy & Corp. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
7,739
-15.91%
|
$394,689
$51.7 P/Share
|
|
Aug 15
2021
|
Michele Holcomb EVP - Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
8,511
+14.89%
|
-
|
|
Aug 12
2021
|
Michael C Kaufmann CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
68,631
-11.19%
|
$3,500,181
$51.69 P/Share
|
|
Aug 12
2021
|
Michael C Kaufmann CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
76,909
+11.14%
|
$3,153,269
$41.6 P/Share
|
|
Aug 03
2021
|
Michele Holcomb EVP - Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
9,337
+18.88%
|
-
|
|
Aug 03
2021
|
Michael C Kaufmann CEO |
BUY
Grant, award, or other acquisition
|
Direct |
98,866
+15.56%
|
-
|
|
Aug 03
2021
|
Ola M Snow Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,929
+6.85%
|
-
|
|
Aug 03
2021
|
Victor L. Crawford CEO, Pharmaceutical Segment |
BUY
Grant, award, or other acquisition
|
Direct |
23,946
+21.97%
|
-
|
|
Aug 03
2021
|
Stephen M Mason CEO, GMPD Segment |
BUY
Grant, award, or other acquisition
|
Direct |
7,209
+11.05%
|
-
|
|
Aug 03
2021
|
Jessica L Mayer Chief Legal/Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,190
+21.51%
|
-
|
|
Aug 03
2021
|
Brian S Rice Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,291
+19.5%
|
-
|
|
Jun 28
2021
|
Michael C Kaufmann CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,962
-1.57%
|
$396,834
$57.28 P/Share
|
|
May 15
2021
|
Jason M. Hollar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,033
-5.21%
|
$113,848
$56.34 P/Share
|
|
Mar 15
2021
|
Jessica L Mayer Chief Legal/Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
911
-7.22%
|
$51,927
$57.35 P/Share
|
|
Feb 26
2021
|
Jessica L Mayer Chief Legal/Compliance Officer |
SELL
Open market or private sale
|
Direct |
3,500
-21.72%
|
$178,500
$51.53 P/Share
|
|
Feb 15
2021
|
Brian S Rice Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-4.96%
|
$69,003
$51.86 P/Share
|
|
Feb 11
2021
|
Patricia M English Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,291
-35.1%
|
$167,841
$51.98 P/Share
|
|
Dec 01
2020
|
Michael C Kaufmann CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,206
-0.72%
|
$173,124
$54.59 P/Share
|
|
Nov 15
2020
|
Victor L. Crawford CEO, Pharmaceutical Segment |
SELL
Payment of exercise price or tax liability
|
Direct |
4,362
-6.66%
|
$248,634
$57.43 P/Share
|
|
Nov 09
2020
|
Carrie Smith Cox Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+8.57%
|
-
|
|
Nov 09
2020
|
Sheri H. Edison Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+45.07%
|
-
|
|
Nov 09
2020
|
Gregory B Kenny Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,595
+10.76%
|
-
|
|
Nov 09
2020
|
Dean A Scarborough Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+31.01%
|
-
|
|
Nov 09
2020
|
Nancy Killefer Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+16.54%
|
-
|
|
Nov 09
2020
|
J Michael Losh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+25.05%
|
-
|
|
Nov 09
2020
|
David C Evans Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+42.09%
|
-
|
|
Nov 09
2020
|
Calvin Darden Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+7.77%
|
-
|
|
Nov 09
2020
|
Patricia Hemingway Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+13.45%
|
-
|
|
Nov 09
2020
|
Bruce Downey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+6.52%
|
-
|
|
Nov 09
2020
|
John H Weiland Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+31.01%
|
-
|
|
Nov 09
2020
|
Akhil Johri Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,339
+21.64%
|
-
|
|
Nov 08
2020
|
Michael C Kaufmann CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,485
-1.43%
|
$337,220
$52.64 P/Share
|
|
Oct 15
2020
|
Ola M Snow Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
593
-1.58%
|
$28,464
$48.37 P/Share
|